Panoramica dell'azienda
rYojbaba Co., Ltd. operates within the Industrials sector, specifically serving the Consulting Services industry, where it delivers specialized labor and corporate consulting solutions alongside health services to a diverse clientele in Japan. The company functions through two distinct operational segments: Consulting Services and Health Services, with the Consulting Services arm focusing on supporting labor unions and corporate entities. In terms of scale, the enterprise holds a market capitalization of $25.26M and employs a workforce of 128 individuals. Its annual revenue for the trailing twelve months stands at $9.34M, figures that indicate a mid-sized position within the Japanese market for specialized consulting and health support. The combination of a relatively modest market cap and a specific focus on labor and corporate consulting suggests the company targets niche requirements rather than broad-scale industrial manufacturing, positioning it as a specialized service provider rather than a dominant market leader in the broader industrials complex.
Salute finanziaria
The company reported a revenue of $9.34M for the trailing twelve months, with a net income of $119,394 and an EBITDA of $-59,921. The significant gap between the positive net income and the negative EBITDA reveals a cost structure where interest expenses or depreciation charges are substantial enough to turn earnings before interest and taxes negative, yet still allowing for a small amount of profit after taxes. Despite the negative EBITDA, the company generated a free cash flow of $1.46M, which indicates a high degree of financial flexibility and the ability to fund operations or return capital without relying on external financing. Profitability is further contextualized by a gross margin of 26.6%, an operating margin of -33.6%, and a profit margin of 1.3%, illustrating that while the core service delivery is profitable on a gross basis, significant operational costs are eroding those gains before tax. The balance sheet presents a leveraged profile with total debt of $9.09M against cash reserves of $6.16M, resulting in a debt-to-equity ratio of 149.22. This leverage implies that the company relies heavily on creditor financing relative to shareholder equity, which increases financial risk but may amplify returns if earnings improve. Liquidity is robust, evidenced by a current ratio of 2.70, which indicates that the company holds sufficient current assets to cover its short-term obligations nearly three times over. However, the return metrics reveal mixed management effectiveness, with a return on equity of 2.8% and a return on assets of -2.9%, suggesting that the capital base is not currently generating strong value creation relative to the assets employed or the equity invested.
Valutazione del valore
The trailing twelve-month P/E ratio stands at 218.74, while the forward P/E is not available, a discrepancy that implies the market is pricing in significant uncertainty regarding future earnings growth or potential volatility in the upcoming fiscal periods. The price-to-book ratio is 4.14, indicating that the market values the company at a substantial premium of over four times its book value, which often reflects intangible assets or growth expectations not fully captured on the balance sheet. Alternative valuation metrics provide further insight, with a price-to-sales ratio of 2.71 and an EV/EBITDA of -470.63; the negative EV/EBITDA stems from the negative EBITDA, suggesting that valuation models based on operating cash flow are currently skewed by the company's current profitability challenges. The stock's price has historically ranged between a 52-week low of $1.81 and a 52-week high of $11.43, meaning the current trading price sits in a range that reflects significant recent volatility. Although the beta value is not available, the wide spread between the high and low suggests that the stock price is highly sensitive to market sentiment and sector-specific factors within the consulting and health services industries.
Growth & Income
For the trailing twelve months, revenue growth year-over-year was -34.3%, while earnings growth is not available due to the small absolute value of net income; this contraction in revenue implies that the company is currently shrinking its top line, which naturally constrains the ability to generate higher earnings unless margins expand significantly. The company does not pay dividends, as indicated by a dividend yield of N/A and a payout ratio of 0.0%, meaning that all available earnings are theoretically available for reinvestment rather than distribution to shareholders. This reinvestment strategy is typical for companies in a turnaround phase or those prioritizing internal growth and debt reduction over shareholder payouts. The overall growth and income profile is characterized by a decline in revenue and an absence of dividend distributions, positioning the stock primarily for investors seeking exposure to a small-cap Japanese industrial service provider undergoing structural changes rather than for those seeking immediate income or consistent top-line expansion.